SEC Company Response from Evolus, (EOLS) — Jun 10, 2026
Evolus, Inc.
Date: June 10, 2026 · CIK: 0001570562 · Accession: 0001570562-26-000074
AI Filing Summary & Sentiment
File numbers found in text: 333-296556
Show Raw Text
CORRESP 1 filename1.htm Document Evolus, Inc. 520 Newport Center Dr., Suite 1200 Newport Beach, CA 92660 June 10, 2026 VIA EDGAR Division of Corporation Finance Office of Life Sciences United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3628 Attention: Jason Drory Re: Request for Effectiveness for Evolus, Inc. Registration Statement on Form S-3 (File No. 333-296556) Dear Mr. Drory: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Evolus, Inc. (the “ Registrant ”) hereby respectfully requests that the effectiveness of the above-referenced Registration Statement be accelerated to 4:00 p.m. Eastern Time, on June 12, 2026, or as soon thereafter as practicable. The Registrant respectfully requests that you notify Andra Troy of O’Melveny & Myers LLP of such effectiveness by telephone at (212) 728-5731. If you have any questions or comments regarding the foregoing, please do not hesitate to contact Ms. Troy at the telephone number above. Very truly yours, Evolus, Inc. By: /s/ Jeffrey Plumer Name: Jeffrey Plumer Title: General Counsel & Corporate Secretary cc: Andra Troy, O’Melveny & Myers LLP David Moatazedi, Evolus, Inc.